| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c1e68abd266058a1839fa4bcd96afa0a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7bce595c861dba361078ba893e4713be |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0038
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00 |
| filingDate |
2001-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0bb173e2bdaedeef452f641e6a27cc42 |
| publicationDate |
2001-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0191794-A2 |
| titleOfInvention |
Vitamin d3 analogs as radiosensitizers for the treatment of cancer |
| abstract |
The present invention is drawn to the use of a vitamin D3 analog in combination with radiation therapy for the treatment of hyperproliferative diseases, including cancer. Such combination therapies may be combined with additional therapies such as chemotherapy, immunotherapy, gene therapy or surgery. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2524419-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007035489-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007035489-A3 |
| priorityDate |
2000-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |